Dec 1 (Reuters) - Orchard Therapeutics PLC:
* ORCHARD THERAPEUTICS ANNOUNCES SWISSMEDIC VALIDATION OF MARKETING AUTHORIZATION APPLICATION FOR LIBMELDY (ATIDARSAGENE AUTOTEMCEL)
* ORCHARD THERAPEUTICS PLC - COMPANY EXPECTS TO RECEIVE SWISSMEDIC'S ASSESSMENT REPORT IN FIRST HALF OF 2023 Source text for Eikon: Further company coverage: